COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Use a Handoff tool for optimal patient transitions of care, effectively transfer responsibility & accountability with this Project Firstline program.
Close the loop to prevent miscommunication and missteps; call out, check back and verify to close the loop with this Project Firstline program.
Receiving two doses of the Pfizer or Moderna COVID-19 vaccine during pregnancy might help prevent your infant from being hospitalized for COVID-19 in the first six months after birth, according a study released today by the Centers for Disease Control and Prevention.
Resources from Association for the Health
Care Environment - AHE, American Society for Health
Care Engineers - ASHE, and Teamtraing
The Food and Drug Administration announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved.
Pfizer asked the Food and Drug Administration to authorize for emergency use two 3-microgram doses of its COVID-19 vaccine for children aged 6 months through 4.
Once the COVID-19 omicron variant became prominent through Jan. 8, unvaccinated adults in Los Angeles County had a 3.6 times higher SARS-CoV-2 infection rate and 23 times higher hospitalization rate than adults who had received a COVID-19 vaccine booster, the Centers for Disease Control and…
The Centers for Medicare & Medicaid Services’ (CMS) accelerated/advance payment program provides necessary funds when there are disruptions in claims submission and/or processing.
The Food and Drug Administration issued an update on the Class 1 recall of certain Philips Respironics ventilators.
The Food and Drug Administration granted full approval to the Moderna COVID-19 vaccine for individuals age 18 and older.